Alert issued over one batch of Calcichew-D3 500mg/400 IU Caplets

Alert issued over one batch of Calcichew-D3 500mg/400 IU Caplets

November 30 2017 A drug alert has been issued for a batch of Calcichew-D3 500mg/400 IU Caplets...

Viagra Connect to be available as an OTC medicine

Viagra Connect to be available as an OTC medicine

November 29 2017 Pfizer has announced that it will launch Viagra Connect as a Pharmacy (P)...

Self Care Week picks up publics frustrations around GP appointments

Self Care Week picks up publics frustrations around GP appointments

November 14 2017 One in ten people says they are driven to exaggerate symptoms in order to get a...

Vaping should be ‘promoted’ as smoking cessation aid

Vaping should be ‘promoted’ as smoking cessation aid

October 17 2017 Electronic cigarettes should be promoted as a method of stopping smoking, the...

MHRA issues Drug Safety Updates for loperamide and miconazole

MHRA issues Drug Safety Updates for loperamide and miconazole

October 4 2017 The medicines regulator, the MHRA, has issued Drug Safety Updates on two...

  • Alert issued over one batch of Calcichew-D3 500mg/400 IU Caplets

    Alert issued over one batch of Calcichew-D3 500mg/400 IU Caplets

    Thursday, 30 November 2017 09:26
  • Viagra Connect to be available as an OTC medicine

    Viagra Connect to be available as an OTC medicine

    Wednesday, 29 November 2017 12:46
  • Self Care Week picks up publics frustrations around GP appointments

    Self Care Week picks up publics frustrations around GP appointments

    Tuesday, 14 November 2017 18:58
  • Vaping should be ‘promoted’ as smoking cessation aid

    Vaping should be ‘promoted’ as smoking cessation aid

    Tuesday, 17 October 2017 14:31
  • MHRA issues Drug Safety Updates for loperamide and miconazole

    MHRA issues Drug Safety Updates for loperamide and miconazole

    Wednesday, 04 October 2017 16:25

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a bmj logo cbAugust 25 2017

Using dietary supplements containing anti-oxidants, zinc and copper can help delay progression of macular degeneration and could be a cost-effective approach to eye care.

With the supplements being relatively inexpensive compared to drugs used to treat disorders such as ‘wet’ age-related macular degeneration, the supplements should be available on the NHS, the researchers have also proposed.

The findings are made in the British Journal of Ophthalmology. Researchers from London and the US evaluated the cost-effectiveness of certain supplements in patients with either bilateral intermediate age-related macular degeneration or unilateral neovascular age-related macular degeneration AMD (nAMD). Quality-adjusted life years (QALYs) and healthcare costs were the main outcome measures when compared to no intervention.

There was an improvement in both QALY with supplements and cost savings over the lifetime of the patient. Depending on the type of combination supplement given, they can be “both cost saving and more effective than no supplement use and should therefore be considered in public health policy.”

Reporting on the study, the BMJ Newsroom said two formulations were trialled. “Formulation 1 contained high doses of vitamins C and E, beta carotene, zinc and copper; in formulation 2, beta carotene was replaced with lutein and zeaxanthin, but the other constituents remained the same. Both formulations are commercially available.

“Their analysis showed that both formulations are cost effective for treating patients with early stage ‘wet’ AMD, but they were more cost effective for those with the condition in just one eye.”

Links:
BMJ Newsroom announcement                  
AY Lee et al. ‘Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data’. British Journal of Ophthalmology. August 2017                  

 

OTC News

January 22 2018 Plans by the main NHS education organisation for England to expand training programmes for community pharmacy have been welcomed by the Royal Pharmaceutical Society.
January 22nd 2018 NHS England will launch a public health campaign promoting community pharmacies to parents with young children next month.